Medicare’s new device coverage pathway — breakthrough or breakdown?

New England Journal of Medicine

10 March 2021 - CMS recently finalised a rule that could substantially alter Medicare coverage decisions for certain new medical devices. 

The rule is intended to expedite coverage, but it would undermine Medicare’s authority to consider the clinical evidence supporting device adoption.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Market access , Medicare , Device